Shedding light on therapeutics in alopecia and their relevance to COVID-19
December 2020 The Institute of Trichologists’ President Professor Andrew Messenger collaborated in a study that reported on therapeutics in alopecia and their relevance to COVID-19. ABSTRACT: As of July 9, 2020, there were more than 12 million confirmed cases of coronavirus disease 2019 (COVID-19) across the globe, with more than 550,000 deaths. Many European countries, including Belgium, […]
Shedding light on therapeutics in alopecia and their relevance to COVID-19 Read More »